4 | | - | AN ACT concerning health. |
---|
5 | | - | Be it enacted by the People of the State of Illinois, |
---|
6 | | - | represented in the General Assembly: |
---|
7 | | - | Section 5. The Lyme Disease Prevention and Protection Act |
---|
8 | | - | is amended by changing Section 15 as follows: |
---|
9 | | - | (410 ILCS 450/15) |
---|
10 | | - | Sec. 15. Lyme Disease Task Force; duties; members. |
---|
11 | | - | (a) The Department shall establish the Lyme Disease Task |
---|
12 | | - | Force to advise the Department on disease prevention and |
---|
13 | | - | surveillance and provider and public education relating to the |
---|
14 | | - | disease. |
---|
15 | | - | (b) The Task Force shall consist of the Director of Public |
---|
16 | | - | Health or a designee, who shall serve as chairman, and the |
---|
17 | | - | following members: |
---|
18 | | - | (1) one representative from the Department of |
---|
19 | | - | Financial and Professional Regulation, appointed by the |
---|
20 | | - | Director of Public Health; |
---|
21 | | - | (2) 3 physicians licensed to practice medicine in all |
---|
22 | | - | its branches who are members of a statewide organization |
---|
23 | | - | representing physicians, one of whom represents a medical |
---|
24 | | - | school faculty and one of whom has the experience of |
---|
25 | | - | treating Lyme disease, appointed by the Director of Public |
---|
26 | | - | Health; |
---|
| 3 | + | 1 AN ACT concerning health. |
---|
| 4 | + | 2 Be it enacted by the People of the State of Illinois, |
---|
| 5 | + | 3 represented in the General Assembly: |
---|
| 6 | + | 4 Section 5. The Lyme Disease Prevention and Protection Act |
---|
| 7 | + | 5 is amended by changing Section 15 as follows: |
---|
| 8 | + | 6 (410 ILCS 450/15) |
---|
| 9 | + | 7 Sec. 15. Lyme Disease Task Force; duties; members. |
---|
| 10 | + | 8 (a) The Department shall establish the Lyme Disease Task |
---|
| 11 | + | 9 Force to advise the Department on disease prevention and |
---|
| 12 | + | 10 surveillance and provider and public education relating to the |
---|
| 13 | + | 11 disease. |
---|
| 14 | + | 12 (b) The Task Force shall consist of the Director of Public |
---|
| 15 | + | 13 Health or a designee, who shall serve as chairman, and the |
---|
| 16 | + | 14 following members: |
---|
| 17 | + | 15 (1) one representative from the Department of |
---|
| 18 | + | 16 Financial and Professional Regulation, appointed by the |
---|
| 19 | + | 17 Director of Public Health; |
---|
| 20 | + | 18 (2) 3 physicians licensed to practice medicine in all |
---|
| 21 | + | 19 its branches who are members of a statewide organization |
---|
| 22 | + | 20 representing physicians, one of whom represents a medical |
---|
| 23 | + | 21 school faculty and one of whom has the experience of |
---|
| 24 | + | 22 treating Lyme disease, appointed by the Director of Public |
---|
| 25 | + | 23 Health; |
---|
33 | | - | (3) one advanced practice registered nurse selected |
---|
34 | | - | from the recommendations of professional nursing |
---|
35 | | - | associations, appointed by the Director of Public Health; |
---|
36 | | - | (4) one local public health administrator, appointed |
---|
37 | | - | by the Director of Public Health; |
---|
38 | | - | (5) one veterinarian, who must be a practicing Doctor |
---|
39 | | - | of Veterinary Medicine, appointed by the Director of |
---|
40 | | - | Public Health; |
---|
41 | | - | (6) one medical entomologist, appointed by the |
---|
42 | | - | Director of Public Health; |
---|
43 | | - | (7) (6) 4 members of the public interested in Lyme |
---|
44 | | - | disease, appointed by the Director of Public Health; |
---|
45 | | - | (8) (7) 2 members appointed by the Speaker of the |
---|
46 | | - | House of Representatives; |
---|
47 | | - | (9) (8) 2 members appointed by the Minority Leader of |
---|
48 | | - | the House of Representatives; |
---|
49 | | - | (10) (9) 2 members appointed by the President of the |
---|
50 | | - | Senate; and |
---|
51 | | - | (11) (10) 2 members appointed by the Minority Leader |
---|
52 | | - | of the Senate. |
---|
53 | | - | (c) The terms of the members of the Task Force shall be 3 |
---|
54 | | - | years. Members may continue to serve after the expiration of a |
---|
55 | | - | term until a new member is appointed. Each member appointed to |
---|
56 | | - | fill a vacancy occurring prior to the expiration of the term |
---|
57 | | - | for which his predecessor was appointed shall be appointed for |
---|
58 | | - | the remainder of such term. The council shall meet as |
---|
| 32 | + | HB2855 Enrolled- 2 -LRB103 30901 CPF 57441 b HB2855 Enrolled - 2 - LRB103 30901 CPF 57441 b |
---|
| 33 | + | HB2855 Enrolled - 2 - LRB103 30901 CPF 57441 b |
---|
| 34 | + | 1 (3) one advanced practice registered nurse selected |
---|
| 35 | + | 2 from the recommendations of professional nursing |
---|
| 36 | + | 3 associations, appointed by the Director of Public Health; |
---|
| 37 | + | 4 (4) one local public health administrator, appointed |
---|
| 38 | + | 5 by the Director of Public Health; |
---|
| 39 | + | 6 (5) one veterinarian, who must be a practicing Doctor |
---|
| 40 | + | 7 of Veterinary Medicine, appointed by the Director of |
---|
| 41 | + | 8 Public Health; |
---|
| 42 | + | 9 (6) one medical entomologist, appointed by the |
---|
| 43 | + | 10 Director of Public Health; |
---|
| 44 | + | 11 (7) (6) 4 members of the public interested in Lyme |
---|
| 45 | + | 12 disease, appointed by the Director of Public Health; |
---|
| 46 | + | 13 (8) (7) 2 members appointed by the Speaker of the |
---|
| 47 | + | 14 House of Representatives; |
---|
| 48 | + | 15 (9) (8) 2 members appointed by the Minority Leader of |
---|
| 49 | + | 16 the House of Representatives; |
---|
| 50 | + | 17 (10) (9) 2 members appointed by the President of the |
---|
| 51 | + | 18 Senate; and |
---|
| 52 | + | 19 (11) (10) 2 members appointed by the Minority Leader |
---|
| 53 | + | 20 of the Senate. |
---|
| 54 | + | 21 (c) The terms of the members of the Task Force shall be 3 |
---|
| 55 | + | 22 years. Members may continue to serve after the expiration of a |
---|
| 56 | + | 23 term until a new member is appointed. Each member appointed to |
---|
| 57 | + | 24 fill a vacancy occurring prior to the expiration of the term |
---|
| 58 | + | 25 for which his predecessor was appointed shall be appointed for |
---|
| 59 | + | 26 the remainder of such term. The council shall meet as |
---|
61 | | - | frequently as the chairman deems necessary, but not less than |
---|
62 | | - | 4 2 times each year. Members shall receive no compensation for |
---|
63 | | - | their services. |
---|
64 | | - | (d) The Lyme Disease Task Force has the following duties |
---|
65 | | - | and responsibilities: |
---|
66 | | - | (1) monitoring the implementation of this Act and |
---|
67 | | - | providing feedback and input for necessary additions or |
---|
68 | | - | modifications; |
---|
69 | | - | (2) reviewing relevant literature and guidelines that |
---|
70 | | - | define accurate diagnosis of Lyme disease with the purpose |
---|
71 | | - | of creating cohesive and consistent guidelines for the |
---|
72 | | - | determination of Lyme diagnosis across all counties in |
---|
73 | | - | Illinois and with the intent of providing accurate and |
---|
74 | | - | relevant numbers to the Centers for Disease Control and |
---|
75 | | - | Prevention; |
---|
76 | | - | (3) providing recommendations on professional |
---|
77 | | - | continuing educational materials and opportunities that |
---|
78 | | - | specifically focus on Lyme disease prevention, protection, |
---|
79 | | - | and treatment; and |
---|
80 | | - | (4) assisting the Department in establishing policies, |
---|
81 | | - | procedures, techniques, and criteria for the collection, |
---|
82 | | - | maintenance, exchange, and sharing of medical information |
---|
83 | | - | on Lyme disease, and identifying persons or entities with |
---|
84 | | - | Lyme disease expertise to collaborate with Department in |
---|
85 | | - | Lyme disease diagnosis, prevention, and treatment. |
---|
86 | | - | (Source: P.A. 100-1137, eff. 1-1-19; 101-606, eff. 12-13-19.) |
---|
| 62 | + | |
---|
| 63 | + | |
---|
| 64 | + | |
---|
| 65 | + | HB2855 Enrolled - 2 - LRB103 30901 CPF 57441 b |
---|
| 66 | + | |
---|
| 67 | + | |
---|
| 68 | + | HB2855 Enrolled- 3 -LRB103 30901 CPF 57441 b HB2855 Enrolled - 3 - LRB103 30901 CPF 57441 b |
---|
| 69 | + | HB2855 Enrolled - 3 - LRB103 30901 CPF 57441 b |
---|
| 70 | + | 1 frequently as the chairman deems necessary, but not less than |
---|
| 71 | + | 2 4 2 times each year. Members shall receive no compensation for |
---|
| 72 | + | 3 their services. |
---|
| 73 | + | 4 (d) The Lyme Disease Task Force has the following duties |
---|
| 74 | + | 5 and responsibilities: |
---|
| 75 | + | 6 (1) monitoring the implementation of this Act and |
---|
| 76 | + | 7 providing feedback and input for necessary additions or |
---|
| 77 | + | 8 modifications; |
---|
| 78 | + | 9 (2) reviewing relevant literature and guidelines that |
---|
| 79 | + | 10 define accurate diagnosis of Lyme disease with the purpose |
---|
| 80 | + | 11 of creating cohesive and consistent guidelines for the |
---|
| 81 | + | 12 determination of Lyme diagnosis across all counties in |
---|
| 82 | + | 13 Illinois and with the intent of providing accurate and |
---|
| 83 | + | 14 relevant numbers to the Centers for Disease Control and |
---|
| 84 | + | 15 Prevention; |
---|
| 85 | + | 16 (3) providing recommendations on professional |
---|
| 86 | + | 17 continuing educational materials and opportunities that |
---|
| 87 | + | 18 specifically focus on Lyme disease prevention, protection, |
---|
| 88 | + | 19 and treatment; and |
---|
| 89 | + | 20 (4) assisting the Department in establishing policies, |
---|
| 90 | + | 21 procedures, techniques, and criteria for the collection, |
---|
| 91 | + | 22 maintenance, exchange, and sharing of medical information |
---|
| 92 | + | 23 on Lyme disease, and identifying persons or entities with |
---|
| 93 | + | 24 Lyme disease expertise to collaborate with Department in |
---|
| 94 | + | 25 Lyme disease diagnosis, prevention, and treatment. |
---|
| 95 | + | 26 (Source: P.A. 100-1137, eff. 1-1-19; 101-606, eff. 12-13-19.) |
---|
| 96 | + | |
---|
| 97 | + | |
---|
| 98 | + | |
---|
| 99 | + | |
---|
| 100 | + | |
---|
| 101 | + | HB2855 Enrolled - 3 - LRB103 30901 CPF 57441 b |
---|